SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001567619-21-002215
Filing Date
2021-02-04
Accepted
2021-02-04 17:33:22
Documents
2
Period of Report
2021-02-04

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 5780
2 poa_neylan.htm EX-24 7558
  Complete submission text file 0001567619-21-002215.txt   14652
Mailing Address 51 CHARLES LINDBERGH BOULEVARD UNIONDALE NY 11553
Business Address 51 CHARLES LINDBERGH BOULEVARD UNIONDALE NY 11553 (415) 655-4899
Angion Biomedica Corp. (Issuer) CIK: 0001601485 (see all company filings)

IRS No.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address
Neylan John F. (Reporting) CIK: 0001640447 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39990 | Film No.: 21592435